IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
05.05.2025 - 05.06.2025
Swiss Biotech Day offers high-level experts from the life science industry the opportunity to network, discuss and discover trends in R&D, manufacturing, data management, artificial intelligence and innovative financing.
05.07.2025 - 05.09.2025
Since 2006, BIO Korea has been holding this international convention every year to invigorate and grow the global bio-health industry, offering attendees the opportunity to learn about the newest bio-health trends and technology, as well as network with bio-health industry academics, professionals, and leaders.
05.15.2025
Join Cambrex expert Todd Sprouse, Associate Director of Analytical Services, as he reviews insights and case studies for how a product-specific, stepwise testing approach can help detect, quantify and control nitrosamine impurities while maintaining cost efficiency.
05.19.2025 - 05.22.2025
TIDES USA, hosted by the Informa Connect, is the industry’s largest and most renowned event to accelerate your oligo and peptide therapeutics to market, cross-pollinating expertise across oligonucleotides, peptides, mRNA, genome editing and drug delivery.
05.20.2025 - 05.22.2025
Join us at CPHI Americas, the premier event connecting the pharmaceutical drug development and manufacturing end-to-end supply chain, to learn, innovate, and collaborate with a global network of pharma professionals.
06.11.2025 - 06.12.2025
BOS Basel brings together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships – it’s where business gets done.
06.15.2025 - 06.19.2025
The 29th annual American Peptide Symposium, “Peptides Rising,” features lectures from world renowned peptide scientists, emerging talents, and trailblazing leaders in the field of peptide science.